Together, these results provide an additional mechanism by which loss of Slc4a4 modulates BBB function and astrocytic CCL2 via regulating arginine to citrulline/NO conversion in the context of ischemic stroke. This evidence concerns the gene SLC4A4 and ischemic stroke.